SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹1,156 Cr | ₹852 Cr | ₹918 Cr | ₹345 Cr | ₹191 Cr |
What is the latest Net Current Assets ratio of SUVEN PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹1,156 Cr |
Mar2023 | ₹852 Cr |
Mar2022 | ₹918 Cr |
Mar2021 | ₹345 Cr |
Mar2020 | ₹191 Cr |
How is Net Current Assets of SUVEN PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹1,156 Cr | 35.67 | |
Mar2023 | ₹852 Cr | -7.12 | |
Mar2022 | ₹918 Cr | 165.95 | |
Mar2021 | ₹345 Cr | 80.39 | |
Mar2020 | ₹191 Cr | - |
Compare Net Current Assets of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹28,771.1 Cr | 7.1% | 2.5% | 74.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 7.1% |
2.5% |
74.1% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses